Outcomes Among Mechanically Ventilated Patients With Severe Pneumonia and Acute Hypoxemic Respiratory Failure From SARS-CoV-2 and Other Etiologies.

Item request has been placed! ×
Item request cannot be made. ×
loading   Processing Request
  • Additional Information
    • Source:
      Publisher: American Medical Association Country of Publication: United States NLM ID: 101729235 Publication Model: Electronic Cited Medium: Internet ISSN: 2574-3805 (Electronic) Linking ISSN: 25743805 NLM ISO Abbreviation: JAMA Netw Open Subsets: MEDLINE
    • Publication Information:
      Original Publication: Chicago, IL : American Medical Association, [2018]-
    • Subject Terms:
    • Abstract:
      Importance: Early observations suggested that COVID-19 pneumonia had a higher mortality rate than other causes of pneumonia.
      Objective: To compare outcomes between mechanically ventilated patients with pneumonia due to COVID-19 (March 2020 to June 2021) and other etiologies (July 2016 to December 2019).
      Design, Setting, and Participants: This retrospective cohort study was conducted at the Johns Hopkins Healthcare System among adult patients (aged ≥18 years) with pneumonia who required mechanical ventilation in the first 2 weeks of hospitalization. Clinical, laboratory, and mechanical ventilation data were extracted from admission to hospital discharge or death.
      Exposures: Pneumonia due to COVID-19.
      Main Outcomes and Measures: The primary outcome was 90-day in-hospital mortality. Secondary outcomes were time to liberation from mechanical ventilation, hospital length of stay, static respiratory system compliance, and ventilatory ratio. Unadjusted and multivariable-adjusted logistic regression, proportional hazards regression, and doubly robust regression were used in propensity score-matched sets to compare clinical outcomes.
      Results: Overall, 719 patients (mean [SD] age, 61.8 [15.3] years; 442 [61.5%] were male; 460 [64.0%] belonged to a minoritized racial group and 253 [35.2%] were White) with severe COVID-19 pneumonia and 1127 patients (mean [SD] age, 60.9 [15.8] years; 586 [52.0%] were male; 459 [40.7%] belonged to a minoritized racial group and 655 [58.1%] were White) with severe non-COVID-19 pneumonia. In unadjusted analyses, patients with COVID-19 pneumonia had higher 90-day mortality (odds ratio, 1.21, 95% CI 1.04-1.41), longer time on mechanical ventilation (subdistribution hazard ratio 0.72, 95% CI 0.63-0.81), and lower compliance (32.0 vs 28.4 mL/kg PBW/cm H2O; P < .001) when compared with those with non-COVID-19 pneumonia. In propensity score-matched analyses, patients with COVID-19 pneumonia were equally likely to die within 90 days as those with non-COVID-19 pneumonia (odds ratio, 1.04; 95% CI, 0.81 to 1.35; P = .85), had similar respiratory system compliance (mean difference, 1.82 mL/cm H2O; 95% CI, -1.53 to 5.17 mL/cm H2O; P = .28) and ventilatory ratio (mean difference, -0.05; 95% CI, -0.22 to 0.11; P = .52), but had lower rates of liberation from mechanical ventilation (subdistribution hazard ratio, 0.81; 95% CI, 0.65 to 1.00) when compared with those with non-COVID-19 pneumonia. Patients with COVID-19 pneumonia had somewhat lower rates of being discharged from the hospital alive at 90 days (subdistribution hazard ratio, 0.83; 95% CI, 0.68 to 1.01) than those with non-COVID-19 pneumonia; however, this was not statistically significant.
      Conclusions and Relevance: In this study, mechanically ventilated patients with severe COVID-19 pneumonia had similar mortality rates as patients with other causes of severe pneumonia but longer times to liberation from mechanical ventilation. Mechanical ventilation use in COVID-19 pneumonia should follow the same evidence-based guidelines as for any pneumonia.
    • References:
      Crit Care. 2020 Aug 28;24(1):529. (PMID: 32859264)
      Ann Am Thorac Soc. 2020 Sep;17(9):1158-1161. (PMID: 32432896)
      Intensive Care Med. 2020 Dec;46(12):2200-2211. (PMID: 32728965)
      Intensive Care Med. 2020 Nov;46(11):2035-2047. (PMID: 33034689)
      Crit Care. 2021 Jul 15;25(1):248. (PMID: 34266454)
      Chest. 2016 Aug;150(2):307-13. (PMID: 26836924)
      Stat Sci. 2010 Feb 1;25(1):1-21. (PMID: 20871802)
      Dev Psychol. 2008 Mar;44(2):395-406. (PMID: 18331131)
      Lancet. 2020 Jun 6;395(10239):1763-1770. (PMID: 32442528)
      Nature. 2021 Feb;590(7847):635-641. (PMID: 33429418)
      JAMA. 2020 Jun 9;323(22):2329-2330. (PMID: 32329799)
      Lancet Respir Med. 2020 Sep;8(9):853-862. (PMID: 32735842)
      Ann Am Thorac Soc. 2021 Apr;18(4):632-640. (PMID: 33183067)
      Am J Respir Crit Care Med. 2020 May 15;201(10):1299-1300. (PMID: 32228035)
      Ann Am Thorac Soc. 2021 Nov;18(11):1876-1885. (PMID: 33577740)
      Thorax. 2003 May;58(5):377-82. (PMID: 12728155)
      Crit Care. 2019 Nov 27;23(1):374. (PMID: 31775846)
      Intensive Care Med. 2016 Oct;42(10):1567-1575. (PMID: 27620287)
      Lancet Respir Med. 2021 Mar;9(3):239-250. (PMID: 33428871)
      EClinicalMedicine. 2020 Oct;27:100518. (PMID: 32864588)
      Crit Care Med. 2021 Sep 1;49(9):1524-1534. (PMID: 33861551)
      Intensive Care Med. 2020 Jun;46(6):1099-1102. (PMID: 32291463)
      Ann Am Thorac Soc. 2021 Jul;18(7):1202-1210. (PMID: 33544045)
      Crit Care. 2021 Feb 8;25(1):52. (PMID: 33557868)
      Crit Care Med. 2021 Oct 1;49(10):e1037-e1039. (PMID: 33826588)
      Am J Respir Crit Care Med. 2021 Dec 1;204(11):1274-1285. (PMID: 34543591)
      Intensive Care Med. 2021 Jan;47(1):60-73. (PMID: 33211135)
      Am J Respir Crit Care Med. 2020 Jun 15;201(12):1560-1564. (PMID: 32348678)
      Lancet Respir Med. 2021 Dec;9(12):1377-1386. (PMID: 34653374)
      Ann Intensive Care. 2021 Jun 7;11(1):92. (PMID: 34097145)
      Br J Anaesth. 2009 May;102(5):692-7. (PMID: 19346233)
      Lancet Respir Med. 2021 Feb;9(2):139-148. (PMID: 33169671)
      Ann Pharmacother. 2022 Feb;56(2):117-123. (PMID: 34075807)
    • Grant Information:
      F32 HL160039 United States HL NHLBI NIH HHS; K23 HL155507 United States HL NHLBI NIH HHS; T32 HL007534 United States HL NHLBI NIH HHS
    • Publication Date:
      Date Created: 20230110 Date Completed: 20230112 Latest Revision: 20230204
    • Publication Date:
      20240829
    • Accession Number:
      PMC9856712
    • Accession Number:
      10.1001/jamanetworkopen.2022.50401
    • Accession Number:
      36626168